Korro Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Revenue	0	0	14.07	36.98	28.95	0	0
Revenue Growth (YoY)	-	-	-61.96%	27.76%	-	-	-
Gross Profit	0	0	14.07	36.98	28.95	0	0
Selling, General & Admin	27.28	16.8	37.18	27.12	14.84	7.06	4.34
Research & Development	57.25	42.2	60.92	37.42	18.78	11.88	11.97
Other Operating Expenses	0	0	0	0	16	0	0
Operating Expenses	84.53	59	98.1	64.53	49.62	18.94	16.31
Operating Income	-84.53	-59	-84.03	-27.55	-20.68	-18.94	-16.31
Interest Expense / Income	0	0	0.37	-0.99	-1.78	0.11	0.17
Other Expense / Income	-3.39	-0.98	0.27	-0.08	-0.15	0.12	3.76
Pretax Income	-81.15	-58.02	-84.67	-26.48	-18.75	-19.17	-20.24
Income Tax	0.03	0.01	0.02	0.04	0	0	0
Net Income	-81.17	-58.03	-84.69	-26.51	-18.75	-19.17	-20.24
Preferred Dividends	0	0	0	0	1.05	0	0
Net Income Common	-81.17	-58.03	-84.69	-26.51	-19.8	-19.17	-20.24
Shares Outstanding (Basic)	2	0	1	1	0	0	0
Shares Outstanding (Diluted)	2	0	1	1	0	0	0
Shares Change	499.32%	-62.86%	6.50%	272.90%	465.24%	117.70%	-
EPS (Basic)	-53.08	-227.42	-123.50	-41.00	-114.50	-626.50	-1439.50
EPS (Diluted)	-53.08	-227.42	-123.50	-41.00	-114.50	-626.50	-1439.50
Free Cash Flow	-75.12	-58.86	-78.97	-51.86	33.15	-17.46	-16.48
Free Cash Flow Per Share	-49.12	-230.65	-114.95	-80.39	191.65	-570.51	-1172.04
Gross Margin	-	-	100.00%	100.00%	100.00%	-	-
Operating Margin	-	-	-597.32%	-74.49%	-71.42%	-	-
Profit Margin	-	-	-601.98%	-71.68%	-68.40%	-	-
Free Cash Flow Margin	-	-	-561.37%	-140.22%	114.53%	-	-
EBITDA	-73.91	-54.12	-80.46	-25.89	-19.72	-18.41	-19.53
EBITDA Margin	-	-	-571.96%	-70.00%	-68.11%	-	-
Depreciation & Amortization	7.24	3.91	3.84	1.58	0.81	0.65	0.53
EBIT	-81.15	-58.02	-84.3	-27.47	-20.53	-19.06	-20.06
EBIT Margin	-	-	-599.26%	-74.28%	-70.92%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).